ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3-Reference-Cited by-同舟云学术

ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3

Published:2021-07 Issue: Volume:510 Page:13-23
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Coppo Roberto^ORCID,Orso Francesca,Virga Federico,Dalmasso Alberto,Baruffaldi Desirée,Nie Lei,Clapero Fabiana,Dettori Daniela,Quirico Lorena,Grassi Elena^ORCID,Defilippi Paola^ORCID,Provero Paolo^ORCID,Valdembri Donatella^ORCID,Serini Guido^ORCID,Sadeghi Mehran M.,Mazzone Massimiliano,Taverna Daniela

Funder

Airc Italian Foundation for Cancer Research

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference72 articles.

1. Treatment of advanced melanoma in 2020 and beyond;Jenkins;J. Invest. Dermatol.,2020

2. Cancer statistics, 2020;Siegel;Ca - Cancer J. Clin.,2020

3. The genetic evolution of melanoma;Shain;N. Engl. J. Med.,2016

4. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq;Tirosh;Science,2016

5. Melanoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. H2 antihistamines: May be useful for combination therapies in cancer?;Biochemical Pharmacology;2024-05

2. Antiphotoaging and Skin-Protective Activities of Ardisia silvestris Ethanol Extract in Human Keratinocytes;Plants;2023-03-03

3. miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1;Molecular and Cellular Probes;2022-12

4. Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker;Frontiers in Pharmacology;2022-08-11